NCT06578000 (Iontophoresis) is a Phase 1 clinical trial of Magnesium sulfate in Lateral Epicondylitis, sponsored by NOUR ALI ABO EL ELAA FRAGHLY.

Who is sponsoring NCT06578000?

NCT06578000 is sponsored by NOUR ALI ABO EL ELAA FRAGHLY.

What drugs are being tested in NCT06578000?

Interventions in NCT06578000: Magnesium sulfate, conventional therapy.

What condition does NCT06578000 study?

NCT06578000 studies Lateral Epicondylitis.

Is NCT06578000 still recruiting?

NCT06578000 is currently recruiting now. Last updated 29 August 2024.

Last reviewed 2024-08-29 · How we verify

NCT06578000: Iontophoresis

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients

Recruiting now Phase 1 Last updated 29 August 2024

What this trial tests

Phase 1 trial testing Magnesium sulfate in Lateral Epicondylitis in 40 participants. Currently enrolling.

Timeline

1 September 2024

Primary endpoint
30 November 2024

2 March 2025

Quick facts

Lead sponsor	NOUR ALI ABO EL ELAA FRAGHLY
Phase	Phase 1
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	1 September 2024
Primary completion	30 November 2024
Estimated completion	2 March 2025
Sites	1 location across Egypt

Drugs / interventions tested

Magnesium sulfate — full drug profile →
conventional therapy — full drug profile →

Conditions studied

Lateral Epicondylitis — all drugs for Lateral Epicondylitis →

Sponsor

NOUR ALI ABO EL ELAA FRAGHLY

Who can join

Adults 20 to 50, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is conducted To evaluate the effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transdermal needle-free drug delivery approaches and activation mechanism.
Sasikala A, Tran DT, Zhang J, Nguyen NT. · · 2026 · PMID 41909222 · DOI 10.1016/j.mtbio.2026.103002

Verify or expand the search:

Other trials of Magnesium sulfate

Trials testing the same drug.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07438366 — Adding Magnesium Sulphate to Combined Pectointercostal Plane and Erector Spinae Plane Blocks for Acute and Chronic Post- · NA · not yet recruiting
NCT07213037 — Magnesium Sulfate Versus Lidocaine as Additives to Dexmedetomidine for Cough Suppression After Functional Endoscopic Sin · Phase 3 · not yet recruiting
NCT06979141 — Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia · Phase 3 · recruiting
NCT07131033 — Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholec · Phase 1, PHASE2 · active not recruiting

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

NCT07424794 — Mobilization With Movement Verses Cyriax Techniques Among Athletes With Lateral Epicondylitis · NA · recruiting
NCT07365033 — Eccentric Exercise With Blood Flow Restriction vs Resistance Training for Lateral Epicondylitis · NA · recruiting
NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis · Phase 4 · recruiting
NCT07410663 — Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis · active not recruiting
NCT07314840 — Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06578000 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NOUR ALI ABO EL ELAA FRAGHLY
Last refreshed: 29 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06578000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing